Chief Physician, Associate Professor, and Doctoral Supervisor of the Department of Gastrointestinal Medical Oncology at Peking University Cancer Hospital. Graduated with a bachelor's degree from Shanghai Medical University in 1998, obtained a doctoral degree from Peking University Health Science Center in 2004, and conducted visiting research at UPMC and MSKCC in the United States in 2014. Dedicated to precision pharmacotherapy for gastrointestinal malignancies, translational research, and the development of novel anti-tumor drugs and technologies. Concurrently serves as Chair of the Gastrointestinal Stromal Tumor Committee of the Chinese Society of Clinical Oncology, Vice Chair of the Tumor Drug Clinical Research Committee of the Chinese Anti-Cancer Association, Vice Chair of the Clinical Research Committee of the Chinese Society of Clinical Oncology, and member of the Multidisciplinary Diagnosis and Treatment Expert Group for Digestive Tract Tumors of the National Health Commission, receiving special government allowances. Led or participated in the formulation of the National Health Commission's diagnostic and treatment standards for colorectal cancer, the Chinese Society of Clinical Oncology's guidelines for the diagnosis and treatment of gastrointestinal stromal tumors, and the Chinese Society of Clinical Oncology's guidelines for the diagnosis and treatment of colorectal cancer. Served as principal investigator or key project member in the Ministry of Science and Technology's major special research projects on colorectal cancer, the Ministry of Science and Technology's major new drug platform creation research, and the National Natural Science Foundation of China's general projects. Received the First Prize of the Chinese Medical Association's Science and Technology Award and the First Prize of the Chinese Anti-Cancer Association's Science and Technology Award. Published over 60 SCI papers on research findings.